An Exploratory Biomarker Study of RO5045337 in Patients With Liposarcomas Prior to Debulking Surgery
Phase of Trial: Phase I
Latest Information Update: 10 Jun 2016
At a glance
- Drugs RG 7112 (Primary)
- Indications Liposarcoma
- Focus Biomarker; Pharmacodynamics
- Sponsors Roche
- 10 Jun 2017 Biomarkers information updated
- 21 May 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
- 21 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.